Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,813 | 7,051 | 8,359 | 9,682 | 10,918 |
| Marketable Securities | 347 | 288 | 552 | 493 | 834 |
| Receivables | 202 | 155 | 507 | 462 | 342 |
| Inventories | 38 | 40 | 32 | 27 | 30 |
| TOTAL | $6,978 | $8,291 | $10,572 | $10,901 | $12,443 |
| Non-Current Assets | |||||
| PPE Net | 368 | 406 | 431 | 466 | 459 |
| Intangibles | 488 | 441 | 411 | 379 | 365 |
| TOTAL | $856 | $846 | $842 | $845 | $824 |
| Total Assets | $7,834 | $9,138 | $11,415 | $11,746 | $13,267 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 8 | 8 | 8 | 8 |
| Accounts payable and accrued liabilities | 120 | 90 | 61 | 173 | 55 |
| TOTAL | $194 | $207 | $166 | $238 | $153 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 316 | 271 | 235 | 212 | 202 |
| TOTAL | $7 | $18 | $29 | $40 | $50 |
| Total Liabilities | $201 | $225 | $195 | $277 | $203 |
| Shareholders' Equity | |||||
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -39,099 | -37,631 | -35,248 | -33,822 | -31,829 |
| TOTAL | $7,949 | $9,183 | $11,455 | $11,681 | $13,266 |
| Total Liabilities And Equity | $8,150 | $9,409 | $11,650 | $11,958 | $13,469 |